These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 20737516

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD, Kundhur D, Solomons K, Yatham LN, Lam RW.
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S.
    Hum Psychopharmacol; 2008 Mar; 23(2):79-86. PubMed ID: 17972359
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial.
    Ko YH, Lew YM, Jung SW, Joe SH, Lee CH, Jung HG, Lee MS.
    J Clin Psychopharmacol; 2008 Aug; 28(4):375-83. PubMed ID: 18626263
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Open trial of mirtazapine in patients with fibromyalgia.
    Samborski W, Lezanska-Szpera M, Rybakowski JK.
    Pharmacopsychiatry; 2004 Jul; 37(4):168-70. PubMed ID: 15467973
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J, Prochazka J, Odén A, Sjödin I, Dahl ML, Ahlner J, Bengtsson F.
    Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
    [Abstract] [Full Text] [Related]

  • 39. [Comparative efficacy of remeron (mirtazapine) and amitriptyline in treatment of patients with depression of moderate intensity].
    Iakovlev VA, Belinskiĭ AV, Dorovskikh IV, Zhbrykunov VL.
    Voen Med Zh; 2000 Oct; 321(10):27-9. PubMed ID: 11334006
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.